3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
44
Lymphoma, Follicular
28
Lymphoma, Mantle-Cell
27
Leukemia, Lymphocytic, Chronic, B-Cell
27
Lymphoma
26
Lymphoma, Non-Hodgkin
24
Lymphoma, B-Cell, Marginal Zone
16
Lymphoma, B-Cell
14
Recurrence
12
Burkitt Lymphoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Waldenstrom Macroglobulinemia
8
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Hodgkin Disease
3
Hematologic Neoplasms
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Anemia, Refractory, with Excess of Blasts
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Off-Label Use
×
Rituximab
×
90 days
×
Clear all
No trials found.